hfpef semaglutide Weight loss drug benefits obese patients presenting with HFpEF, type 2 diabetes Semaglutide in HFpEF across obesity
Description
(1,2) The incidence of peripartum cardiomyopathy (PPCM) is 4x higher in black women than in white women
It appears that some GLP-1 receptor agonists have a central brain effect and may be anti-inflammatory or stimulate brain recovery. What does this mean for the future of mental health treatment
At Flow, I didnt feel rushed or brushed offthey actually explained what was going on with my body and gave me a plan that makes sense
Thogersen H
However, there are risks associated with its use, including endometrial cancer or abnormalities, uterine cancer, uterine polyps, and bone thinning, especially among women aged 40
The FDA continues to monitor the safety of Ozempic and similar medications through its post-marketing surveillance systems
